Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ERCC3, RAD25, 2071, ENSG00000163161, GTF2H, TFIIH, BTF2, P19447, XPB AND Treatment
10 results:

  • 1. PHD1 regulates p53-mediated colorectal cancer chemoresistance.
    Deschoemaeker S; Di Conza G; Lilla S; Martín-Pérez R; Mennerich D; Boon L; Hendrikx S; Maddocks OD; Marx C; Radhakrishnan P; Prenen H; Schneider M; Myllyharju J; Kietzmann T; Vousden KH; Zanivan S; Mazzone M
    EMBO Mol Med; 2015 Oct; 7(10):1350-65. PubMed ID: 26290450
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study.
    Negru S; Papadopoulou E; Apessos A; Stanculeanu DL; Ciuleanu E; Volovat C; Croitoru A; Kakolyris S; Aravantinos G; Ziras N; Athanasiadis E; Touroutoglou N; Pavlidis N; Kalofonos HP; Nasioulas G
    BMJ Open; 2014 May; 4(5):e004652. PubMed ID: 24859998
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Interactions between SAP155 and FUSE-binding protein-interacting repressor bridges c-Myc and P27Kip1 expression.
    Matsushita K; Tamura M; Tanaka N; Tomonaga T; Matsubara H; Shimada H; Levens D; He L; Liu J; Yoshida M; Nomura F
    Mol Cancer Res; 2013 Jul; 11(7):689-98. PubMed ID: 23594796
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. cancer screening practices of cancer survivors: population-based, longitudinal study.
    Grunfeld E; Moineddin R; Gunraj N; Del Giudice ME; Hodgson DC; Kwon JS; Elit L
    Can Fam Physician; 2012 Sep; 58(9):980-6. PubMed ID: 22972732
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A population-based study of follow-up care for Hodgkin lymphoma survivors: opportunities to improve surveillance for relapse and late effects.
    Hodgson DC; Grunfeld E; Gunraj N; Del Giudice L
    Cancer; 2010 Jul; 116(14):3417-25. PubMed ID: 20564062
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Endoscopic submucosal dissection and preoperative assessment with endoscopic ultrasonography for the treatment of rectal carcinoid tumors.
    Ishii N; Horiki N; Itoh T; Maruyama M; Matsuda M; Setoyama T; Suzuki S; Uchida S; Uemura M; Iizuka Y; Fukuda K; Suzuki K; Fujita Y
    Surg Endosc; 2010 Jun; 24(6):1413-9. PubMed ID: 20033710
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. c-myc suppressor FBP-interacting repressor for cancer diagnosis and therapy.
    Matsushita K; Tomonaga T; Kajiwara T; Shimada H; Itoga S; Hiwasa T; Kubo S; Ochiai T; Matsubara H; Nomura F
    Front Biosci (Landmark Ed); 2009 Jan; 14(9):3401-8. PubMed ID: 19273283
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Laparoscopic versus open surgery for rectal cancer: a meta-analysis.
    Aziz O; Constantinides V; Tekkis PP; Athanasiou T; Purkayastha S; Paraskeva P; Darzi AW; Heriot AG
    Ann Surg Oncol; 2006 Mar; 13(3):413-24. PubMed ID: 16450220
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. DNA alkylation-induced phosphorylation of p53 and activation of kinases in colon cancer cells.
    Jaiswal AS; Narayan S
    Int J Oncol; 2001 Sep; 19(3):613-6. PubMed ID: 11494044
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. RNA synthesis block by 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) triggers p53-dependent apoptosis in human colon carcinoma cells.
    te Poele RH; Okorokov AL; Joel SP
    Oncogene; 1999 Oct; 18(42):5765-72. PubMed ID: 10523857
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.